- Home
- WFC vs ABT Comparison
WFC vs ABT Comparison
Compare WFC & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WFC | ABT |
|---|---|---|
| Founded | 1852 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.1B | 222.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WFC | ABT |
|---|---|---|
| Price | $92.32 | $125.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 18 |
| Target Price | $90.50 | ★ $146.61 |
| AVG Volume (30 Days) | ★ 13.8M | 6.7M |
| Earning Date | 01-14-2026 | 01-21-2026 |
| Dividend Yield | ★ 1.94% | 1.88% |
| EPS Growth | 26.82 | ★ 141.97 |
| EPS | 6.07 | ★ 7.96 |
| Revenue | ★ $79,072,000,000.00 | $43,843,000,000.00 |
| Revenue This Year | $8.85 | $7.56 |
| Revenue Next Year | $5.12 | $7.96 |
| P/E Ratio | ★ $15.28 | $15.76 |
| Revenue Growth | 1.54 | ★ 6.37 |
| 52 Week Low | $58.42 | $110.86 |
| 52 Week High | $93.42 | $141.23 |
Technical Indicators
Market Signals| Indicator | WFC | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 71.60 | 48.47 |
| Support Level | $88.19 | $120.70 |
| Resistance Level | $91.11 | $126.05 |
| Average True Range (ATR) | 1.89 | 2.22 |
| MACD | 0.64 | -0.24 |
| Stochastic Oscillator | 94.78 | 52.46 |
Price Performance
Historical ComparisonAbout WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.0 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.